Cart
sales@molnova.com
Ac-Adhesin (1025-1044) amide
CAS No. 320350-56-9
Ac-Adhesin (1025-1044) amide( ——— )
Catalog No. M41939 CAS No. 320350-56-9
Acetyl-Adhesin (1025-1044) amide is a 20-peptide fragment of Streptococcus pyogenes cell surface adhesin that acts as an antimicrobial peptide to specifically inhibit the binding of adhesin to salivary receptors and prevent recolonization of Streptococcus pyogenes.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | Get Quote | Get Quote |
|
| 50MG | Get Quote | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
Biological Information
-
Product NameAc-Adhesin (1025-1044) amide
-
NoteResearch use only, not for human use.
-
Brief DescriptionAcetyl-Adhesin (1025-1044) amide is a 20-peptide fragment of Streptococcus pyogenes cell surface adhesin that acts as an antimicrobial peptide to specifically inhibit the binding of adhesin to salivary receptors and prevent recolonization of Streptococcus pyogenes.
-
DescriptionAcetyl-Adhesin (1025-1044) amide is a 20-peptide fragment of Streptococcus pyogenes cell surface adhesin that acts as an antimicrobial peptide to specifically inhibit the binding of adhesin to salivary receptors and prevent recolonization of Streptococcus pyogenes.
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number320350-56-9
-
Formula Weight2202.51
-
Molecular FormulaC97H160N26O32
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. C G Kelly, et al. ?A synthetic peptide adhesion epitope as a novel antimicrobial agent. Nat Biotechnol. 1999 Jan;17(1):42-7.??
molnova catalog
related products
-
Nonacosane
Methyl linoleate has antioxidant activity.
-
G-R-G-E-T-P
G-R-G-E-T-P
-
FFAGLDD TFA
FFAGLDD TFA is an MMP9 selective cleavage peptide, which is used for the cytoplasmic transfer of doxorubicin (DOX) to realize the controlled slow drug delivery and release.
